Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

IMPLANTATKLINIK KØBENHAVN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.9% 2.1% 3.5% 2.7% 3.0% 2.3% 18.1% 18.1%   Credit score (0-100)   71 69 53 58 57 63 8 8   Credit rating   A A BBB BBB BBB BBB B B   Credit limit (kDKK)   0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -253 -351 -306 -291 -381 -378 0.0 0.0   EBITDA   -1,400 -1,452 -908 -1,404 -2,621 -1,235 0.0 0.0   EBIT   -2,128 -2,170 -1,461 -1,634 -2,798 -1,390 0.0 0.0   Pre-tax profit (PTP)   1,866.7 791.8 1,183.5 3,636.1 5,063.1 4,238.7 0.0 0.0   Net earnings   1,486.5 649.2 867.9 2,831.7 3,955.0 3,022.1 0.0 0.0   Pre-tax profit without non-rec. items   1,867 792 1,183 3,636 5,063 4,239 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,604 991 538 307 815 660 0.0 0.0   Shareholders equity total   2,698 1,847 1,715 3,347 4,302 3,324 124 124   Interest-bearing liabilities   16,201 17,229 14,413 14,936 16,677 21,980 0.0 0.0   Balance sheet total (assets)   20,515 20,338 17,334 19,979 24,361 29,006 124 124   Net Debt   11,493 13,141 13,329 13,510 14,924 19,069 -124 -124     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -253 -351 -306 -291 -381 -378 0.0 0.0   Gross profit growth   20.4% -38.4% 12.7% 5.1% -31.2% 0.9% 0.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   20,515 20,338 17,334 19,979 24,361 29,006 124 124   Balance sheet change%   2.9% -0.9% -14.8% 15.3% 21.9% 19.1% -99.6% 0.0%   Added value   -1,400.3 -1,452.5 -908.5 -1,403.9 -2,567.3 -1,235.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,152 -1,436 -1,105 -461 332 -310 -660 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   839.6% 619.1% 477.3% 562.5% 734.2% 368.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.6% 7.5% 9.7% 23.1% 26.0% 20.0% 0.0% 0.0%   ROI %   13.3% 7.8% 10.1% 24.1% 28.4% 22.1% 0.0% 0.0%   ROE %   50.3% 28.6% 48.7% 111.9% 103.4% 79.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   13.2% 9.1% 9.9% 16.8% 17.7% 11.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -820.8% -904.7% -1,467.2% -962.3% -569.3% -1,543.8% 0.0% 0.0%   Gearing %   600.5% 932.7% 840.3% 446.3% 387.7% 661.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.5% 4.4% 4.1% 4.6% 4.5% 5.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.1 1.1 1.2 0.8 0.7 0.0 0.0   Current Ratio   1.1 1.1 1.1 1.2 0.8 0.7 0.0 0.0   Cash and cash equivalent   4,707.7 4,088.4 1,084.4 1,425.9 1,753.4 2,911.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,668.3 -2,083.1 1,733.6 3,794.1 -4,646.7 -8,851.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -700 -726 -454 -702 -1,284 -618 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -700 -726 -454 -702 -1,311 -618 0 0   EBIT / employee   -1,064 -1,085 -730 -817 -1,399 -695 0 0   Net earnings / employee   743 325 434 1,416 1,977 1,511 0 0